Dual antiplatelet therapy improves functional recovery and inhibits inflammation after cerebral ischemia/reperfusion injury

BACKGROUND: Dual antiplatelet therapy with aspirin and clopidogrel (ASA + CPG) during the first 21 days has been shown to reduce the risk of major ischemic events in patients with transient ischemic attack (TIA) or minor stroke. However, the mechanisms underlying combination treatment with ASA + CPG...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Wen, Liu, Xiangrong, Liu, Wenqian, Wang, Chunjuan, Zhao, Shunying, Wen, Shaohong, Gong, Ting, Chen, Wentao, Chen, Qingfang, Ye, Weizhen, Li, Zixiao, Wang, Yongjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9011245/
https://www.ncbi.nlm.nih.gov/pubmed/35433995
http://dx.doi.org/10.21037/atm-22-735

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9011245/
https://www.ncbi.nlm.nih.gov/pubmed/35433995
http://dx.doi.org/10.21037/atm-22-735

Ejemplares similares